Data integrity remains at the forefront of global regulatory inspections. Health authorities—including the US FDA, EMA, Health Canada, and PMDA—continue to issue warning letters and non-compliance notices for data management failures in pharmaceutical operations. Achieving sustainable compliance requires moving beyond memorizing the ALCOA+ framework to embedding practical, automated controls within [...]